Jim Simons’s Rani Therapeutics RANI Stock Holding History

Jim Simons’s Portfolio RANI Stock Details RANI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$328K	Buy	+430,737	New	+$382K	﹤0.01%	2746
2025 Q4	–	Sell	-24,908	Closed	-$12.4K	–	3667
2025 Q3	$12.4K	Buy	+24,908	New	+$13K	﹤0.01%	3445
2024 Q4	–	Sell	-33,199	Closed	-$71.7K	–	3846
2024 Q3	$71.7K	Buy	33,199 +11,499	+53%	+$32.9K	﹤0.01%	3307
2024 Q2	$82.5K	Sell	21,700 -48,600	-69%	-$252K	﹤0.01%	3218
2024 Q1	$219K	Buy	70,300 +26,600	+61%	+$91.5K	﹤0.01%	3199
2023 Q4	$145K	Sell	43,700 -7,300	-14%	-$16.9K	﹤0.01%	3220
2023 Q3	$111K	Sell	51,000 -37,201	-42%	-$142K	﹤0.01%	3224
2023 Q2	$363K	Buy	88,201 +47,084	+115%	+$219K	﹤0.01%	3040
2023 Q1	$212K	Buy	41,117 +2,717	+7%	+$16.3K	﹤0.01%	3255
2022 Q4	$227K	Buy	+38,400	New	+$280K	﹤0.01%	3363

Other funds holding RANI

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

AIC

AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return

Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Jim Simons's RANI Position: Q2 2026 in Review

Jim Simons opened a new position in Rani Therapeutics (RANI) in Q2 2026: 430,737 shares worth $328K. The stake represents ﹤0.01% of the portfolio and ranks #2746 among its holdings. This is a return to the name: Jim Simons previously reported a position in RANI as recently as Q3 2025.

Jim Simons first reported a position in RANI in Q4 2022 and has held it in 10 quarters since. The position peaked at $363K in Q2 2023. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

Jim Simons held 430,737 shares of Rani Therapeutics worth $328K as of Q2 2026.
Rani Therapeutics was a new Jim Simons position in Q2 2026.
Rani Therapeutics made up ﹤0.01% of Jim Simons's portfolio in Q2 2026, its #2746 holding.
Jim Simons first reported a position in Rani Therapeutics in Q4 2022 and has held it in 10 quarters since.
Jim Simons's Rani Therapeutics position peaked at $363K in Q2 2023.
68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.